Valuation: CVRx, Inc.

Market Cap 137M 120M 111M 102M 192M 13.15B 196M 1.32B 518M 6.44B 514M 503M 22.18B P/E 2026 *
-2.63x
P/E 2027 * -2.72x
Enterprise Value 162M 142M 131M 121M 228M 15.6B 232M 1.56B 614M 7.64B 610M 597M 26.31B EV / Sales 2026 *
2.49x
EV / Sales 2027 * 2.7x
Free-Float
85.82%
Yield 2026 *
-
Yield 2027 * -
1 day+2.23%
1 week-1.71%
Current month+0.78%
1 month+4.02%
3 months-30.75%
6 months-5.30%
Current year-27.04%
1 week 5.03
Extreme 5.03
5.61
1 month 4.76
Extreme 4.76
6.01
Current year 4.37
Extreme 4.3701
9.84
1 year 4.37
Extreme 4.3701
11.3
3 years 4.3
Extreme 4.2993
33.14
5 years 4.3
Extreme 4.2993
33.14
10 years 4.3
Extreme 4.2993
33.14
Manager TitleAgeSince
Chief Executive Officer 60 11/02/2024
Director of Finance/CFO 43 30/09/2020
Chief Operating Officer 57 10/08/2025
Director TitleAgeSince
Director/Board Member 61 30/09/2008
Director/Board Member 57 30/06/2020
Director/Board Member 52 30/06/2020
Date Insider Type Main position Quantity % Market Cap.
05-31Free

Director

19,902 0.0750%
05-31Free

Director

19,902 0.0750%
05-31
Vensana Capital Management LLC
OtherCompany 0 0%
Change 5-day change 1-year change 3-year change Capi.($)
+2.13%-1.71%-27.04%-68.64% 137M
+0.23%-0.22%+33.91%+0.98% 12.44B
-0.34%+2.75%+9.27%+11.65% 5.85B
-4.68%-5.64%+51.49%+25.92% 5.96B
+3.66%+2.20% - - 4.22B
-1.55%+10.23%-30.22%+15.83% 4.25B
+2.24%+3.50%-22.41%-24.23% 3.96B
-0.47%-0.93%-2.00%+255.63% 1.89B
+2.12%-9.44%-6.31%-61.23% 1.8B
+1.66%+2.00%+55.96%-2.86% 1.54B
Average +0.50%-1.22%+6.96%+17.01% 4.2B
Weighted average by Cap. -0.09%+0.16%+16.73%+14.91%

Financials

2026 *2027 *
Net sales 65.28M 57.05M 52.74M 48.73M 91.76M 6.27B 93.42M 629M 247M 3.07B 245M 240M 10.57B 76.18M 66.57M 61.54M 56.86M 107M 7.32B 109M 734M 288M 3.58B 286M 280M 12.34B
Net income -52.82M -46.16M -42.67M -39.42M -74.24M -5.07B -75.59M -509M -200M -2.48B -198M -194M -8.55B -52.14M -45.57M -42.12M -38.92M -73.29M -5.01B -74.61M -502M -197M -2.45B -196M -192M -8.44B
Net Debt 25.51M 22.3M 20.61M 19.04M 35.86M 2.45B 36.51M 246M 96.43M 1.2B 95.83M 93.71M 4.13B 68.44M 59.81M 55.29M 51.08M 96.19M 6.57B 97.94M 659M 259M 3.22B 257M 251M 11.08B
Logo CVRx, Inc.
CVRx, Inc. is a commercial-stage medical device company. The Company is focused on developing, manufacturing and commercializing advanced neuromodulation solutions for patients with cardiovascular diseases. The Company's integrated platform technology, Barostim, is designed to leverage the power of the brain and nervous system to address the imbalance of the autonomic nervous system (ANS), which causes heart failure with reduced ejection fraction (HFrEF) and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy (BAT) by sending imperceptible and persistent electrical pulses to baroreceptors located in the wall of the carotid artery to signal the brain to modulate cardiovascular function. Barostim is a minimally invasive neuromodulation device that consists of two implantable components, an implantable pulse generator (IPG) and a stimulation lead, and is programmed by a wireless clinician-controlled programmer that communicates with the IPG.
Employees
223
Date Price Change Volume
15/07/26 US$5.215 +1.07% 11,432
14/07/26 US$5.160 -4.97% 221,290
13/07/26 US$5.430 0.00% 225,354
10/07/26 US$5.430 +4.42% 140,461
09/07/26 US$5.200 -1.33% 203,370
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
5.160USD
Average target price
11.17USD
Spread / Average Target
+116.41%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CVRX Stock